Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on ...

ImCheck Therapeutics receives EMA Orphan Drug Designation for ICT01 for treatment for acute myeloid leukemia: Marseille, France Thursday, July 24, 2025, 15:00 Hrs [IST] ImCheck Th ...

THE EUROPEAN Hematology Association-European Medicines Agency (EHA2025-EMA) Joint Symposium on minimal residual disease ...

SINGLE clinical trial endpoints often fall short in capturing the full scope of patient experience, particularly in complex ...

Roche is pausing shipments of Elevidys in some countries, following partner Sarepta Therapeutics’ move in the U.S., as safety ...

Abivax's obefazimod resulted in an average 16.4% placebo-adjusted clinical remission rate in UC patients across the two trials.

AI will not replace doctors in a hurry, but platforms like Microsoft AI Diagnostic Orchestrator (MAI-DxO) are improving diagnostic accuracy to levels which is hard to ignore ...

Roche is focusing on early diagnosis of Alzheimer's disease and will soon release its first blood-based biomarker for the ...

Shares of Avidity Biosciences, Inc. (NASDAQ:RNA) rose 4% Wednesday following the announcement that its drug candidate, ...

AUVI-Q® (epinephrine injection, USP) was cleared for use as a part of Axiom Mission 4 that took flight on June 25, 2025.

Studies suggest that some commercially available health tests are inaccurate and unsuitable for public use. Rebecca Coombes , Hristio Boytchev , and Gareth Iacobucci ask if regulation is adequately ...

AstraZeneca said on Thursday its experimental therapy, gefurulimab, met the primary goal and all secondary endpoints in a ...